Clinical Trial Update: A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating an RSV F vaccine in older adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RSV F vaccine (RSV F protein vaccine)

Snippet

Sponsor: Novavax | Conditions: Respiratory Syncytial Virus (RSV) | Phase 3 | Status: COMPLETED